Search

Search Results
Results 1 - 6 of 6 for ER+, PR+, HER2-
  • Breast Cancer Classification
    Health - 22 Jun 2023
    Breast cancers can be classified on the basis of four schemes. Each of these schemes classify the cancers based on different criteria and serve a different purpose.
  • Breast Cancer Prognosis
    Health - 22 Jun 2023
    Prognosis of outlook of any cancer depends on several factors. Notable among these is how early the cancer is detected and treated. The stage of the cancer thus at the beginning of therapy determines...
  • What is Triple Negative Breast Cancer?
    Health - 2 Jan 2023
    Triple negative breast cancer is a type of basal cell cancer where the cancer cells do not display any estrogen receptors (ERs), progesterone receptors (PRs) or HER2 receptors.
  • Breast Cancer Diagnosis
    Health - 22 Jun 2023
    Breast cancer is diagnosed on routine screening procedures or after detection of symptoms. For example, women who notice nipple changes or changes in their breast or feel a lump in their breast may...
  • Breast Cancer Management
    Health - 22 Jun 2023
    Breast cancer treatment has advanced to a stage that, if detected early, most women may survive much longer than they did a few decades ago.
  • What is Invasive Ductal Breast Cancer?
    Health - 16 May 2023
    Invasive ductal breast cancer (IDC) is a cancer that has originated in the cells that line the ducts of the breast but has begun to spread to surrounding breast tissue, with the potential to spread to...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback